Melola Discovery

← Melola Discovery

Jurnal

In Silico Study of Secondary Metabolite in Asiatic Pennywort (Centella asiatica) as a Drug Compound for Blood Cancer (Acute Lymphoblastic Leukemia (ALL)) Targeting JAK-2 Receptor

Indonesian Journal of Chemical Science · Vol. 14 No. 1 (2025) · hlm. 18–27

DOI
10.15294/ijcs.v14i1.8946
ISSN
2502-6844, 2252-6951
Terbit
2025-05-05
Penerbit
Prodi Kimia
Bahasa
eng

Abstrak

Acute Lymphoblastic Leukemia (ALL) is a type of cancer with clinical manifestations such as fever, pallor, bleeding, children appear lethargic, bone and joint pain, enlarged liver, spleen, and enlarged lymph. One of the causes of ALL is due to mutations in the JAK-2 receptor. The purpose of this In Silico study is to find new candidate compounds as ALL therapy in Asiatic Pennywort (Centella asiatica) plant by Lipinski’s RO5 analysis, ADME-Tox, pharmacophore modelling, and molecular docking. The results showed that luteolin can be declared as a lead compound in Asiatic Pennywort plant that has potential in the treatment of acute lymphoblastic leukemia due to its interaction with JAK-2 receptor with an inhibition constant of 0.23736 uM and binding energy of -9.04 kcal/mol. In addition, the predictions of Lipinski's RO5 and ADME-Tox luteolin also meet the requirements to be made into oral preparations and further research can be carried out.

Kata kunci

Jaringan kolaborasi para penulis

17 penulis · 58 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Jambi
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Kevin GabrielAfiliasi tidak diketahui2
Diffa Hauna F. PakhrulAfiliasi tidak diketahui2
Sabiq Salmandhiya HaritsAfiliasi tidak diketahui2
Natasya PrameswariAfiliasi tidak diketahui2
Alya Puteri Agustina PribadiAfiliasi tidak diketahui2
Diah Lia AulifaAfiliasi tidak diketahui2
Rasya Salma FauziyyahAfiliasi tidak diketahui1
Stella Aurelia HuangAfiliasi tidak diketahui1
Apsari Maratus SholehahAfiliasi tidak diketahui1
Tribuana Tungga DewiUniversitas Jambi1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/journals/ijcs/oai, pertama di-harvest 5 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">In Silico Study of Secondary Metabolite in Asiatic Pennywort (Centella asiatica) as a Drug Compound for Blood Cancer  (Acute Lymphoblastic Leukemia (ALL)) Targeting JAK-2 Receptor</dc:title>
	<dc:creator xml:lang="en">Anjelina, Martina</dc:creator>
	<dc:creator xml:lang="en">Renaldi, Fahri</dc:creator>
	<dc:creator xml:lang="en">Shabira, Kalya Kama</dc:creator>
	<dc:creator xml:lang="en">Febriyanti, Selly Trianingrum</dc:creator>
	<dc:creator xml:lang="en">Wulandari, Rizky Prasiska</dc:creator>
	<dc:creator xml:lang="en">Nurdin, Halwa Aulia </dc:creator>
	<dc:creator xml:lang="en">Nuwarda, Rina Fajri </dc:creator>
	<dc:subject xml:lang="en">Asiatic Pennywort, JAK-2 Receptor, Molecular Docking</dc:subject>
	<dc:subject xml:lang="en">Acute Lymphoblastic Leukemia</dc:subject>
	<dc:description xml:lang="en">Acute Lymphoblastic Leukemia (ALL) is a type of cancer with clinical manifestations such as fever, pallor, bleeding, children appear lethargic, bone and joint pain, enlarged liver, spleen, and enlarged lymph. One of the causes of ALL is due to mutations in the JAK-2 receptor. The purpose of this In Silico study is to find new candidate compounds as ALL therapy in Asiatic Pennywort (Centella asiatica) plant by Lipinski’s RO5 analysis, ADME-Tox, pharmacophore modelling, and molecular docking. The results showed that luteolin can be declared as a lead compound in Asiatic Pennywort plant that has potential in the treatment of acute lymphoblastic leukemia due to its interaction with JAK-2 receptor with an inhibition constant of 0.23736 uM and binding energy of -9.04 kcal/mol. In addition, the predictions of Lipinski's RO5 and ADME-Tox luteolin also meet the requirements to be made into oral preparations and further research can be carried out.</dc:description>
	<dc:publisher xml:lang="en">Prodi Kimia</dc:publisher>
	<dc:date>2025-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/journals/ijcs/article/view/8946</dc:identifier>
	<dc:identifier>10.15294/ijcs.v14i1.8946</dc:identifier>
	<dc:source xml:lang="en">Indonesian Journal of Chemical Science; Vol. 14 No. 1 (2025): Indonesian Journal of Chemical Science; 18-27</dc:source>
	<dc:source>2502-6844</dc:source>
	<dc:source>2252-6951</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/journals/ijcs/article/view/8946/3744</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Indonesian Journal of Chemical Science</dc:rights>
</oai_dc:dc>